Further intensive research carried out on a sufficiently large study group seems necessary to better understand the role of adiponectin in the development of ovarian cancer, as well as determine its potential role in diagnosis, prognosis and treatment. This evidence concerns the gene ADIPOQ and ovarian carcinoma.